NCT02778282 (MySafeRx) is a NA clinical trial of MySafeRx™ in Opioid Use Disorder, sponsored by Dartmouth-Hitchcock Medical Center.

Who is sponsoring NCT02778282?

NCT02778282 is sponsored by Dartmouth-Hitchcock Medical Center.

What drugs are being tested in NCT02778282?

Interventions in NCT02778282: MySafeRx™.

What condition does NCT02778282 study?

NCT02778282 studies Opioid Use Disorder.

Is NCT02778282 still recruiting?

NCT02778282 is currently completed. Last updated 5 October 2021.

Last reviewed 2021-10-05 · How we verify

NCT02778282: MySafeRx

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence

Completed NA Last updated 5 October 2021

What this trial tests

NA trial testing MySafeRx™ in Opioid Use Disorder in 27 participants. Completed in 31 August 2021.

Timeline

24 March 2017

Primary endpoint
1 November 2020

31 August 2021

Quick facts

Lead sponsor	Dartmouth-Hitchcock Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	27
Start date	24 March 2017
Primary completion	1 November 2020
Estimated completion	31 August 2021
Sites	3 locations across United States

Drugs / interventions tested

MySafeRx™

Conditions studied

Opioid Use Disorder — all drugs for Opioid Use Disorder →

Sponsor

Dartmouth-Hitchcock Medical Center

Who can join

Adults 18 to 39, any sex, with Opioid Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the MySafeRx study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self- administration of buprenorphine via videoconferencing.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.
Wyse JJ, Morasco BJ, Dougherty J, Edwards B, et al · · 2021 · cited 19× · PMID 34508958 · DOI 10.1016/j.drugalcdep.2021.108923
Assessing the feasibility, usability and acceptability of the <i>MySafeRx</i> platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial.
Janzow GE, Harding C, Flores M, Borodovsky J, et al · · 2022 · PMID 36845988 · DOI 10.1016/j.dadr.2022.100045

Verify or expand the search:

Other trials of MySafeRx™

Trials testing the same drug.

NCT04822168 — Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement in B/N Treatment -RCT · NA · withdrawn

Other recruiting trials for Opioid Use Disorder

Currently open trials in the same condition.

NCT07278518 — Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine · NA · recruiting
NCT07044466 — Social Functioning in Opioid Use Disorder · NA · recruiting
NCT07158853 — Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder · NA · recruiting
NCT06943859 — Ketamine for Opioid Use Disorder · Phase 2 · recruiting
NCT06651177 — Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · Phase 2 · recruiting

Other Dartmouth-Hitchcock Medical Center trials

Trials by the same sponsor.

NCT07325474 — Plan and Protect: Safety Planning for Teens in Rural Emergency Departments · NA · not yet recruiting
NCT07428629 — Piloting an Insomnia Treatment in Patients With Ulcerative Colitis · NA · not yet recruiting
NCT06777511 — Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients · not yet recruiting
NCT07279116 — ABY-029 Head & Neck Trial · Phase 1 · not yet recruiting
NCT07063693 — ABY-029 Glioma Trial · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02778282 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center
Last refreshed: 5 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02778282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing